Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    15601771 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study of Ribavirin to Treat M4 and M5 Acute Myelocytic Leukemia
Condition: Acute Myelocytic Leukemia
Intervention: Drug: ribavirin
2 Unknown  Phase I/II Study of Ribavirin Given as Monotherapy in Solid Tumour Cancer Patients
Condition: Malignant Solid Tumour
Intervention: Drug: Ribavirin
3 Terminated Treatment With Ribavirin for Patients With Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Intervention: Drug: Ribavirin
4 Active, not recruiting Use of Ribavirin and Low Dose Ara-C to Treat Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Interventions: Drug: Ribavirin;   Drug: Cytarabine arabinoside

Indicates status has not been verified in more than two years